MFED 📈 Amundi MSCI EMU ESG CTB - Overview

Exchange: PA • Country: France • Currency: EUR • Type: Etf • ISIN: LU0908501058 • Eurozone Large-Cap Equity

MFED: Stocks, Bonds, Equities, Investments, Funds

‣ Company URL: https://first-eagle.amundi.com/ ‣ Domicile: Luxembourg ‣ Index Name: Morningstar Dev Ezn TME NR EUR

Additional Sources for MFED ETF

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

MFED ETF Overview

Market Cap in USD 580m
Category Eurozone Large-Cap Equity
TER 0.12%
IPO / Inception 2024-02-19

MFED ETF Ratings

Growth 5y 54.5%
Fundamental -
Dividend -
Rel. Strength Industry 142
Analysts -
Fair Price Momentum 257.51 EUR
Fair Price DCF -

MFED Dividends

No Dividends Paid

MFED Growth Ratios

Growth Correlation 3m -31.2%
Growth Correlation 12m 66%
Growth Correlation 5y 83.5%
CAGR 5y 6.78%
CAGR/Mean DD 5y 0.94
Sharpe Ratio 12m 0.55
Alpha -9.18
Beta 0.73
Volatility 10.53%
Current Volume 1.9k
Average Volume 20d 4.4k
What is the price of MFED stocks?
As of December 22, 2024, the stock is trading at EUR 267.40 with a total of 1,941 shares traded.
Over the past week, the price has changed by -1.76%, over one month by +2.35%, over three months by -1.18% and over the past year by +10.64%.
Is Amundi MSCI EMU ESG CTB a good stock to buy?
Partly, yes. Based on ValueRay Analyses, Amundi MSCI EMU ESG CTB (PA:MFED) is currently (December 2024) ok to buy, but has to be watched. It has a Growth Technical Rating of 54.54 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MFED as of December 2024 is 257.51. This means that MFED is currently overvalued and has a potential downside of -3.7%.
Is MFED a buy, sell or hold?
Amundi MSCI EMU ESG CTB has no consensus analysts rating.
What are the forecast for MFED stock price target?
According to ValueRays Forecast Model, MFED Amundi MSCI EMU ESG CTB will be worth about 283.9 in December 2025. The stock is currently trading at 267.40. This means that the stock has a potential upside of +6.16%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 283.9 6.2%